Results 291 to 300 of about 21,878,726 (386)

A retrospective analysis of the efficacy and safety of oral tofacitinib in active vitiligo treatment. [PDF]

Arch Dermatol Res
Hu W, Cao C, Zheng Y, Lei J, Yu K, Sheng A, Jin R, Xu AE.   +7 more
europepmc   +1 more source

Thermodynamics. An Advanced Treatment for Chemists and Physicists

, 1950
E. A. Guggenheim
openalex   +2 more sources

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Treatment decision-making and treatment experiences in men with metastatic castration-resistant prostate cancer. [PDF]

Acta Oncol
Doveson S, Fransson P, Axelsson L, Wennman-Larsen A.   +3 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Understanding the unique goals of complex support clients accessing alcohol and other drug treatment. [PDF]

BMC Health Serv Res
Deans E, Yuen WS, Economidis G, Shakeshaft A, Farnbach S.   +4 more
europepmc   +1 more source

Treatment of Neurasthenia by Teaching of Brain Control

, 1912
White
openalex   +1 more source

Microglial reprogramming: a potential new frontier in enhancing immunotherapy for melanoma brain metastasis

Molecular Oncology, EarlyView.
Microglia act as tumor suppressors during brain metastasis colonization but shift to a tumor‐promoting role after melanoma brain metastases form. NF‐κB/RelA signaling emerges as a key driver of this phenotypic shift. Targeting this pathway reprograms microglia into a pro‐inflammatory state, enhancing antitumor immunity and immune checkpoint inhibitor ...
Noam Savion‐Gaiger, Dorin Bar‐Ziv, Harriet Kluger   +2 more
wiley   +1 more source

Tofacitinib treatment for psoriatic skin lesions associated with Aicardi-Goutières syndrome 7/Singleton-Merten syndrome 1. [PDF]

Orphanet J Rare Dis
Beerepoot S, Grinwis L, Vanderver AL, van der Knaap MS, Kuijpers TW.   +4 more
europepmc   +1 more source

Coordination of the Fundamental Sciences and Clinical Branches in the Diagnosis and Treatment of Disease

, 1935
Barney Brooks
openalex   +1 more source